Geron Corporation (GERN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 01:15PM EDT. Market open.
| Previous Close | 4.0800 |
| Open | 4.1400 |
| Bid | 3.9700 x 200 |
| Ask | 4.0200 x 800 |
| Day's Range | 3.8400 - 4.2000 |
| 52 Week Range | 1.6400 - 4.3000 |
| Volume | |
| Avg. Volume | 13,421,239 |
| Market Cap | 2.344B |
| Beta (5Y Monthly) | 0.61 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates
Geron (GERN) delivered earnings and revenue surprises of 10% and 102.67%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Geron Corporation (NASDAQ:GERN) Is Expected To Breakeven In The Near Future
We feel now is a pretty good time to analyse Geron Corporation's ( NASDAQ:GERN ) business as it appears the company may...
- Zacks
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
Geron Corporation (GERN) and Crinetics Pharmaceuticals (CRNX) gain on positive regulatory and study updates.
© 2024 Yahoo. All rights reserved.